Verastem Oncology (VSTM) Misses Q4 EPS by 102c

Verastem Oncology (NASDAQ: VSTM) reported Q4 EPS of ($1.02).

For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.

You May Also Be Interested In

• Verastem (VSTM) PT Lowered to $13 at Mizuho
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August